|Trial status||Trial closed|
Interventional with experimental drug
|Phase||Trial phase 3|
|Inclusion criteria||- Histologically confirmed MM with measurable disease per IMWG guidelines - Had at least 1 prior anti-MM regimen and no more than 3 prior anti-MM regimens|
The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.